AI Engines For more Details: Perplexity Kagi Labs You
Bone Health: Cheese is rich in calcium, a mineral essential for bone health and development. Adequate calcium intake, along with vitamin D and other nutrients, plays a crucial role in preventing osteoporosis and maintaining bone density. Regular consumption of cheese as part of a balanced diet may help support bone health and reduce the risk of fractures and bone-related disorders.
Heart Health: While cheese contains saturated fats and cholesterol, which have been associated with an increased risk of heart disease when consumed in excess, research suggests that moderate cheese consumption may not significantly impact heart health in healthy individuals. Some studies have even suggested that certain types of cheese, such as aged cheeses like Parmesan and Gouda, may have neutral or favorable effects on cholesterol levels and cardiovascular risk factors when consumed in moderation.
Weight Management: Cheese is calorie-dense and high in fat, which may contribute to weight gain and obesity if consumed in large amounts. However, cheese is also satiating and can be part of a satisfying meal or snack when consumed in appropriate portion sizes. Some research suggests that including moderate amounts of cheese in the diet as part of a balanced meal plan may not adversely affect weight management and could even help promote feelings of fullness and reduce overall calorie intake.
Digestive Health: Cheese contains beneficial bacteria, enzymes, and probiotics that can support digestive health and promote the growth of beneficial gut bacteria. Fermented cheeses, such as certain types of aged cheese and varieties like kefir cheese, may have particularly high probiotic content. These probiotics can help improve digestion, enhance nutrient absorption, and support a healthy gut microbiome.
Lactose Intolerance: Some individuals may be lactose intolerant, meaning they have difficulty digesting lactose, the sugar found in milk and dairy products. While aged cheeses typically contain lower levels of lactose due to the fermentation process, individuals with lactose intolerance may still experience symptoms such as bloating, gas, and diarrhea after consuming cheese. Choosing lactose-free or low-lactose cheese options or taking lactase enzyme supplements can help mitigate symptoms for those with lactose intolerance.
Bone and Tooth Health: Cheese is a good source of phosphorus and protein, which are essential nutrients for bone and tooth health. Phosphorus works together with calcium to form strong bones and teeth, while protein is necessary for tissue repair and maintenance. Including cheese in the diet can contribute to overall dental and skeletal health when consumed as part of a balanced diet.
Nutrient Absorption: The fat content in cheese may aid in the absorption of fat-soluble vitamins such as vitamins A, D, E, and K. These vitamins play crucial roles in various physiological functions, including immune function, vision, blood clotting, and bone health. Pairing cheese with foods rich in fat-soluble vitamins can help enhance their absorption and bioavailability in the body.
Rank | Probiotic | Impact |
---|---|---|
genus | Bifidobacterium | Increases |
species | Akkermansia muciniphila | Reduces |
species | Bacteroides uniformis | Increases |
species | Enterococcus durans | Increases |
species | Enterococcus faecalis | Increases |
species | Enterococcus faecium | Increases |
species | Faecalibacterium prausnitzii | Increases |
species | Hafnia alvei | Increases |
species | Lactococcus cremoris | Increases |
species | Lactococcus lactis | Increases |
species | Streptococcus thermophilus | Increases |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.1 | 0.3 | -2 |
Acne | 1 | 1 | |
ADHD | 0.7 | 2.6 | -2.71 |
Age-Related Macular Degeneration and Glaucoma | 0.2 | 0.3 | -0.5 |
Allergic Rhinitis (Hay Fever) | 1.7 | 2.6 | -0.53 |
Allergies | 4.4 | 2.8 | 0.57 |
Allergy to milk products | 3.7 | 1.7 | 1.18 |
Alopecia (Hair Loss) | 2 | 0.6 | 2.33 |
Alzheimer's disease | 6.3 | 7.1 | -0.13 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 0.8 | 2.6 | -2.25 |
Ankylosing spondylitis | 2.1 | 4.5 | -1.14 |
Anorexia Nervosa | 2.9 | 3 | -0.03 |
Antiphospholipid syndrome (APS) | 1.1 | 1 | 0.1 |
Asthma | 4.1 | 4.8 | -0.17 |
Atherosclerosis | 1.4 | 2.2 | -0.57 |
Atrial fibrillation | 2.8 | 3.8 | -0.36 |
Autism | 6.7 | 6.6 | 0.02 |
Autoimmune Disease | 1.6 | 1.1 | 0.45 |
Barrett esophagus cancer | 1.5 | 1.5 | |
benign prostatic hyperplasia | 1.4 | 1.4 | |
Biofilm | 1.8 | -1.8 | |
Bipolar Disorder | 1.9 | 2.6 | -0.37 |
Brain Trauma | 2.7 | 1.4 | 0.93 |
Cancer (General) | 1 | 0.3 | 2.33 |
Carcinoma | 2.3 | 2.9 | -0.26 |
Celiac Disease | 4.9 | 2.7 | 0.81 |
Cerebral Palsy | 1.5 | 2.4 | -0.6 |
Chronic Fatigue Syndrome | 3.3 | 4.8 | -0.45 |
Chronic Kidney Disease | 1.2 | 1.7 | -0.42 |
Chronic Lyme | 0.8 | 0.3 | 1.67 |
Chronic Obstructive Pulmonary Disease (COPD) | 2.4 | 3.1 | -0.29 |
Chronic Urticaria (Hives) | 1 | 1.4 | -0.4 |
Coagulation / Micro clot triggering bacteria | 3 | 1.1 | 1.73 |
Cognitive Function | 3.1 | 3.8 | -0.23 |
Colorectal Cancer | 3.5 | 7 | -1 |
Constipation | 0.8 | 1.9 | -1.37 |
Coronary artery disease | 2.8 | 2.5 | 0.12 |
COVID-19 | 7.9 | 8.5 | -0.08 |
Crohn's Disease | 5.6 | 7.5 | -0.34 |
Cushing's Syndrome (hypercortisolism) | 0.6 | 0.2 | 2 |
cystic fibrosis | 1.9 | 0.6 | 2.17 |
d-lactic acidosis (one form of brain fog) | 0.8 | -0.8 | |
deep vein thrombosis | 4.4 | 0.9 | 3.89 |
Denture Wearers Oral Shifts | 2.2 | -2.2 | |
Depression | 6.5 | 10.2 | -0.57 |
Dermatomyositis | 0.4 | 0.6 | -0.5 |
Eczema | 1.6 | 2.8 | -0.75 |
Endometriosis | 1.2 | 4.6 | -2.83 |
Eosinophilic Esophagitis | 1.2 | 1.2 | |
Epilepsy | 1.6 | 4.3 | -1.69 |
erectile dysfunction | 1.7 | 0.9 | 0.89 |
Fibromyalgia | 2.5 | 1.3 | 0.92 |
Functional constipation / chronic idiopathic constipation | 3.8 | 6 | -0.58 |
gallstone disease (gsd) | 1.7 | 1.9 | -0.12 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 1.2 | 1.1 | 0.09 |
Generalized anxiety disorder | 2.5 | 2.9 | -0.16 |
giant cell arteritis | 0.1 | 0.1 | |
Glioblastoma | 2 | 0.1 | 19 |
Gout | 1.1 | 5 | -3.55 |
Graves' disease | 4 | 3 | 0.33 |
Gulf War Syndrome | 0.8 | 1.4 | -0.75 |
Halitosis | 1.2 | 1.3 | -0.08 |
Hashimoto's thyroiditis | 2.7 | 3.3 | -0.22 |
Heart Failure | 2.4 | 4.1 | -0.71 |
hemorrhagic stroke | 0.5 | -0.5 | |
Hemorrhoidal disease, Hemorrhoids, Piles | 0.6 | 0.6 | |
Hidradenitis Suppurativa | 1.7 | -1.7 | |
High Histamine/low DAO | 1.6 | 0.8 | 1 |
hypercholesterolemia (High Cholesterol) | 1.6 | 0.4 | 3 |
hyperglycemia | 2 | 1.5 | 0.33 |
Hyperlipidemia (High Blood Fats) | 1.7 | 2.4 | -0.41 |
hypersomnia | 0.8 | 0.2 | 3 |
hypertension (High Blood Pressure | 7.2 | 4.8 | 0.5 |
Hypothyroidism | 2.7 | 0.8 | 2.38 |
Hypoxia | 2.5 | -2.5 | |
IgA nephropathy (IgAN) | 3.4 | 2.2 | 0.55 |
Inflammatory Bowel Disease | 5.7 | 6.1 | -0.07 |
Insomnia | 4.4 | 2.2 | 1 |
Intelligence | 0.4 | 1.3 | -2.25 |
Intracranial aneurysms | 0.8 | 1.3 | -0.63 |
Irritable Bowel Syndrome | 6.7 | 7.9 | -0.18 |
ischemic stroke | 3.5 | 2 | 0.75 |
Liver Cirrhosis | 7.2 | 7 | 0.03 |
Long COVID | 7 | 8 | -0.14 |
Low bone mineral density | 1.3 | 0.7 | 0.86 |
Lung Cancer | 1.5 | 0.6 | 1.5 |
Lymphoma | 1.1 | 1.1 | |
Mast Cell Issues / mastitis | 1.2 | 0.6 | 1 |
ME/CFS with IBS | 2.3 | 1.3 | 0.77 |
ME/CFS without IBS | 1.6 | 1.2 | 0.33 |
membranous nephropathy | 0.6 | -0.6 | |
Menopause | 0.8 | 0.8 | 0 |
Metabolic Syndrome | 8.7 | 8.5 | 0.02 |
Mood Disorders | 6.5 | 9.9 | -0.52 |
multiple chemical sensitivity [MCS] | 0.4 | 1 | -1.5 |
Multiple Sclerosis | 4.8 | 3.6 | 0.33 |
Multiple system atrophy (MSA) | 1.2 | 0.8 | 0.5 |
myasthenia gravis | 1.2 | 1.2 | 0 |
neuropathic pain | 1.7 | 1.7 | |
Neuropathy (all types) | 1.1 | 2 | -0.82 |
neuropsychiatric disorders (PANDAS, PANS) | 1.1 | 1.3 | -0.18 |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 3.8 | 4.7 | -0.24 |
NonCeliac Gluten Sensitivity | 1.6 | 1.7 | -0.06 |
Obesity | 8.8 | 6.3 | 0.4 |
obsessive-compulsive disorder | 2.6 | 4 | -0.54 |
Osteoarthritis | 3.3 | 1.5 | 1.2 |
Osteoporosis | 2.6 | 1.7 | 0.53 |
pancreatic cancer | 0.6 | 2.1 | -2.5 |
Parkinson's Disease | 6.6 | 8.9 | -0.35 |
Peanut Allergy | 0.1 | 0.1 | |
Polycystic ovary syndrome | 3.6 | 5.5 | -0.53 |
Postural orthostatic tachycardia syndrome | 0.6 | 0.3 | 1 |
Premenstrual dysphoric disorder | 0.2 | 0.3 | -0.5 |
primary biliary cholangitis | 2.3 | 2 | 0.15 |
Primary sclerosing cholangitis | 1.8 | 3.1 | -0.72 |
Psoriasis | 2.7 | 4.1 | -0.52 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 7.2 | 7.1 | 0.01 |
Rosacea | 0.9 | 0.4 | 1.25 |
Schizophrenia | 3.8 | 4.6 | -0.21 |
scoliosis | 0.1 | 0.3 | -2 |
sensorineural hearing loss | 0.6 | -0.6 | |
Sjögren syndrome | 2.3 | 1.8 | 0.28 |
Sleep Apnea | 2.8 | 1.3 | 1.15 |
Slow gastric motility / Gastroparesis | 0.3 | 0.9 | -2 |
Small Intestinal Bacterial Overgrowth (SIBO) | 0.2 | 3.1 | -14.5 |
Stress / posttraumatic stress disorder | 3.4 | 3.1 | 0.1 |
Systemic Lupus Erythematosus | 2.8 | 4.2 | -0.5 |
Tic Disorder | 0.6 | 1.9 | -2.17 |
Tourette syndrome | 1 | 1 | 0 |
Type 1 Diabetes | 3.5 | 4.2 | -0.2 |
Type 2 Diabetes | 6.4 | 8.5 | -0.33 |
Ulcerative colitis | 7.3 | 8.6 | -0.18 |
Unhealthy Ageing | 2.6 | 2.6 | 0 |
Vitiligo | 0.7 | 2 | -1.86 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]